Sign in to continue:

Tuesday, March 10th, 2026

Persistence Gold Group Ltd Announces Board Meeting to Approve 2025 Annual Results and Profit Distribution Plan

Persistence Gold Group Ltd Announces Upcoming Board Meeting to Approve 2025 Annual Results

Persistence Gold Group Ltd Schedules Board Meeting to Approve 2025 Annual Results

Key Highlights for Investors

  • Board Meeting Scheduled: The Board of Directors of Persistence Gold Group Ltd (Stock Code: 2489) will convene a meeting on Tuesday, 31 March 2026.
  • Purpose of Meeting: The Board will review and approve the annual results for the financial year ended 31 December 2025. This includes the consolidated financial performance of the Company and its subsidiaries.
  • Profit Distribution Plan: The Board will also consider a proposed profit distribution plan, if any. This could include dividend declarations, which are of significant interest to shareholders.
  • Disclosure to Market: The results and any proposed distributions, once approved, will be published to inform the market and shareholders.

Important Information for Shareholders

  • Price Sensitive Information: The approval and subsequent publication of the Company’s 2025 annual results and any decision regarding profit distribution (such as dividends) can have a direct impact on the Company’s share price.
  • Dividend Expectation: The mention of a profit distribution plan signals the possibility of dividends or other distributions, which is a key consideration for shareholders and potential investors.
  • Leadership: The meeting is being led by Dr. Shao Xuxin, who serves as Chairman, Chief Executive Officer, and Executive Director of the Company, highlighting stable leadership and continuity of management.
  • Board Composition: The Board comprises a mix of executive, non-executive, and independent non-executive directors, reflecting a balanced governance structure:
    • Executive Directors: Dr. Shao Xuxin, Mr. Mackie James Thomas, Mr. Chen Zhuping
    • Non-Executive Director: Mr. Chen Li Bei
    • Independent Non-Executive Directors: Dr. Malaihollo Jeffrey Francis A, Mr. Chan Ngai Fan, Dr. Zeng Ming, Ms. Liu Li

Potential Market Impact

The scheduled review and publication of annual results, coupled with any decision on profit distribution, are events that the market closely watches. Positive financial performance or a generous dividend proposal could boost investor sentiment and potentially drive the share price higher. Conversely, disappointing results or the absence of a distribution plan could have a negative effect. Investors are advised to stay alert for the official announcement following the Board meeting on 31 March 2026.

Conclusion

This upcoming Board meeting represents a critical event for Persistence Gold Group Ltd and its shareholders. The outcomes regarding financial performance and potential profit distribution are likely to influence the Company’s share price and are essential developments for all stakeholders to monitor.


Disclaimer: The information above is based on an official Board meeting notice published by Persistence Gold Group Ltd. Actual outcomes, including the approval of results and profit distribution, will be confirmed only after the Board meeting. Investors should exercise caution and await further official disclosures before making investment decisions.


View PERSISTENCEGOLD Historical chart here



Far East Holdings International Limited Announces Board Meeting to Approve 2025 Final Results and Dividend on March 17, 2026 1

Far East Holdings International Limited Announces Upcoming Board Meeting and Key Decisions Far East Holdings International Limited Announces Upcoming Board Meeting for 2025 Final Results and Dividend Decision Key Points for Investors Date of...

Hansoh Pharmaceutical’s Dalmelitinib Mesylate Tablets NDA Accepted by China’s NMPA for EGFR Mutation-Positive NSCLC Treatment 1

Hansoh Pharmaceutical: New Drug Application Accepted by NMPA Hansoh Pharmaceutical Group Announces Acceptance of New Drug Application for Dalmelitinib Mesylate Tablets by NMPA Key Highlights Hansoh Pharmaceutical Group Company Limited has announced that the...

Pou Sheng International Issues Profit Warning with 57.1% Decline in 2025 Earnings Amid Challenging Mainland China Market 12

Pou Sheng International (Holdings) Limited Issues Significant Profit Warning for FY2025 Pou Sheng International (Holdings) Limited Issues Significant Profit Warning for FY2025 Key Points from the Profit Warning Announcement Pou Sheng International (Holdings) Limited...

   Ad